Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 06, 2019

SELL
$18.93 - $24.75 $2.88 Million - $3.76 Million
-152,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$19.6 - $24.76 $2.98 Million - $3.76 Million
152,000 New
152,000 $3.62 Million
Q3 2018

Nov 06, 2018

SELL
$15.87 - $22.4 $1.46 Million - $2.06 Million
-92,001 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.23 - $30.93 $2.23 Million - $2.85 Million
92,001
92,001 $2.8 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Stone Ridge Asset Management LLC Portfolio

Follow Stone Ridge Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Ridge Asset Management LLC with notifications on news.